3 Stocks I Fully Expect to Double or More Within the Next 5 Years_老虎社区_美港股上老虎

3 Stocks I Fully Expect to Double or More Within the Next 5 Years

The motley fool2021-05-05

DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

JYIN
·2021-05-05
Thanks for sharing this!
回复
点赞
举报
Teckbee
·2021-05-05
Come back in 2026!
回复
点赞
举报
Elgk
·2021-05-05
Like n comment pls tqtq
回复
点赞
举报
Irene104
·2021-05-05
Pls like & comment. Thanks :)
回复
3
举报
收起
- linrui:
  Please like and comment too. Thks.
  2021-05-05
  回复
  举报
- Irene104:
  Ok. Thanks.
  2021-05-05
  回复
  举报
rachhy
·2021-05-05
Everything's so unpredictable
回复
4
举报
Mich77
·2021-05-05
really
回复
4
举报
收起
- Ericlam:
  Nice
  2021-05-06
  回复
  举报
- Mich77:
  thanks
  2021-05-07
  回复
  举报
albert77
·2021-05-05
Cool
回复
1
举报
Huatchin
·2021-05-05
Good
回复
3
举报
收起
- Heng83:
  Good
  2021-05-05
  回复
  举报
- Heng83:
  Haut
  2021-05-05
  回复
  举报
- rachhy:
  goood
  2021-05-05
  回复
  举报
查看更多 2 条评论
Zarkness
·2021-05-05
Which one u believe in? Or not ?
回复
1
举报
lynlim
·2021-05-05
Like and comment
回复
1
举报
收起
- Zarkness:
  Hi lyn
  2021-05-05
  回复
  举报
- Zarkness:
  Hello
  2021-05-05
  回复
  举报
- kctan:
  Ok
  2021-05-05
  回复
  举报
7dee79ac
·2021-05-05
Pls like n comment
回复
3
举报
收起
- Glenn101:
  Like my reply!
  2021-05-05
  回复
  举报
- Zarkness:
  I like ur reply, ,/‘ can like my reply too?
  2021-05-05
  回复
  举报
Julyvictor
·2021-05-05
Comment done
回复
2
举报
收起
- Sashiimi:
  DOnE
  2021-05-05
  回复
  举报
- rachhy:
  ya alright
  2021-05-05
  回复
  举报
Skylarsong
·2021-05-05
Wow a psychic!
回复
1
举报
收起
- njkk:
  Pls like and comment :)
  2021-05-05
  回复
  举报
- Skylarsong:
  I like pancakes
  2021-05-05
  回复
  举报
- carmenng:
  i like waffles
  2021-05-05
  回复
  举报
查看更多 1 条评论
douknowdaway
·2021-05-05
Thanks for sharing, will look into these stocks more. Please like and comment! Much appreciated
回复
6
举报
收起
- Jyen:
  Reply please :)
  2021-05-05
  回复
  举报
- Delvin:
  ReplY back too
  2021-05-05
  回复
  举报
- douknowdaway回复Delvin:
  replied!
  2021-05-06
  回复
  举报
Jyen
·2021-05-05
Please like and comment!
回复
9
举报
收起
- douknowdaway:
  done!
  2021-05-05
  回复
  举报
- J288:
  sure
  2021-05-05
  回复
  举报
Kok
·2021-05-05
Pls like n comment. Tks!!
回复
7
举报
收起
- Jyen:
  Done!
  2021-05-05
  回复
  举报
- J288:
  Sure 😃
  2021-05-05
  回复
  举报
小白添祥
·2021-05-05
Kindly Like & Comment Please. Thank You Very Much
回复
7
举报
收起
- Kok:
  pls reply back. tks!!
  2021-05-05
  回复
  举报
- Jyen:
  Ok!
  2021-05-05
  回复
  举报
- siewbee:
  Reply back pls
  2021-05-05
  回复
  举报
查看更多 2 条评论
Maxcrusader
·2021-05-05
Good read
回复
4
举报
Prydeaux
·2021-05-05
Wow
回复
3
举报
收起
- Angelicious:
  Done
  2021-05-05
  回复
  举报
- Prydeaux:
  Ok
  2021-05-05
  回复
  举报
Angelicious
·2021-05-05
Comment pls
回复
4
举报
收起
- Wanlin:
  Comment
  2021-05-05
  回复
  举报
- Kok:
  pls reply back. tks!!
  2021-05-05
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1183454115?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-05-05 10:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183454115","market":"us","top_or_hot":-1,"title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","media":"The motley fool","content":"<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">网页链接</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ETSY","symbol_name":"Etsy, Inc.","start_time":0,"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","article_id":"1183454115","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","pubTimestamp":1620180427,"sourceInfo":null,"weMediaInfo":null,"summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ETSY":"Etsy, Inc."},"translate_title":"3个股我完全预计未来5年内翻倍或更多","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DMTK":0.9,"ETSY":0.9,"GHVI":0.9},"content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","kind":null,"is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":102835206,"gmtCreate":1620191898505,"gmtModify":1631892801597,"author":{"id":"3579857844356283","authorId":"3579857844356283","name":"JYIN","avatar":"https://static.tigerbbs.com/b337508ff050c1853412bfdd7bc3bd32","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579857844356283","authorIdStr":"3579857844356283"},"htmlText":"Thanks for sharing this!","listText":"Thanks for sharing this!","text":"Thanks for sharing this!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102835206","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102835042,"gmtCreate":1620191851986,"gmtModify":1634207076059,"author":{"id":"3575420065240386","authorId":"3575420065240386","name":"Teckbee","avatar":"https://static.tigerbbs.com/f6f156067aa7b580a64673cf2e93b9ac","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3575420065240386","authorIdStr":"3575420065240386"},"htmlText":"Come back in 2026!&nbsp;","listText":"Come back in 2026!&nbsp;","text":"Come back in 2026!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102835042","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102178316,"gmtCreate":1620189074335,"gmtModify":1634207103415,"author":{"id":"3582942802538500","authorId":"3582942802538500","name":"Elgk","avatar":"https://static.tigerbbs.com/f4e8020d7d7938b137783287f1ce6264","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582942802538500","authorIdStr":"3582942802538500"},"htmlText":"Like n comment pls tqtq&nbsp;","listText":"Like n comment pls tqtq&nbsp;","text":"Like n comment pls tqtq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102178316","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102158024,"gmtCreate":1620187402968,"gmtModify":1634207120211,"author":{"id":"3579485832735627","authorId":"3579485832735627","name":"Irene104","avatar":"https://static.tigerbbs.com/51a81271b5c1b4f1ca7b728f547fc3ba","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3579485832735627","authorIdStr":"3579485832735627"},"htmlText":"Pls like &amp; comment. Thanks :)","listText":"Pls like &amp; comment. Thanks :)","text":"Pls like & comment. Thanks :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/102158024","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4227701,"gmtCreate":1620188975727,"gmtModify":1635503061425,"authorId":3581817420633828,"author":{"id":3581817420633828,"idStr":"3581817420633828","authorId":3581817420633828,"name":"linrui","avatar":"https://static.tigerbbs.com/48b80059ee7e5428aa3ed30a6b83cfcd","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102158024,"type":1,"supId":0,"prevId":0,"content":"Please like and comment too. Thks.","text":"Please like and comment too. Thks.","html":"Please like and comment too. Thks."},{"id":4228475,"gmtCreate":1620195980797,"gmtModify":1635502998237,"authorId":3579485832735627,"author":{"id":3579485832735627,"idStr":"3579485832735627","authorId":3579485832735627,"name":"Irene104","avatar":"https://static.tigerbbs.com/51a81271b5c1b4f1ca7b728f547fc3ba","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102158024,"type":1,"supId":4227701,"prevId":0,"content":"Ok. Thanks.","text":"Ok. Thanks.","html":"Ok. Thanks."}],"langContent":"EN"},{"id":102150398,"gmtCreate":1620187032514,"gmtModify":1634207123008,"author":{"id":"3569563989023705","authorId":"3569563989023705","name":"rachhy","avatar":"https://static.tigerbbs.com/ac0d9804d3e4fa9220d45c8b779c2019","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3569563989023705","authorIdStr":"3569563989023705"},"htmlText":"Everything's so unpredictable","listText":"Everything's so unpredictable","text":"Everything's so unpredictable","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102150398","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102162601,"gmtCreate":1620185788603,"gmtModify":1634207132995,"author":{"id":"3581849551321020","authorId":"3581849551321020","name":"Mich77","avatar":"https://static.tigerbbs.com/e68e0beedd6e067e59c605653c639699","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581849551321020","authorIdStr":"3581849551321020"},"htmlText":"really","listText":"really","text":"really","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/102162601","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4236736,"gmtCreate":1620264904489,"gmtModify":1635502361030,"authorId":3559787818034959,"author":{"id":3559787818034959,"idStr":"3559787818034959","authorId":3559787818034959,"name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102162601,"type":1,"supId":0,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"},{"id":4248269,"gmtCreate":1620350779647,"gmtModify":1635501497760,"authorId":3581849551321020,"author":{"id":3581849551321020,"idStr":"3581849551321020","authorId":3581849551321020,"name":"Mich77","avatar":"https://static.tigerbbs.com/e68e0beedd6e067e59c605653c639699","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102162601,"type":1,"supId":4236736,"prevId":0,"content":"thanks","text":"thanks","html":"thanks"}],"langContent":"EN"},{"id":102117619,"gmtCreate":1620184079831,"gmtModify":1634207143918,"author":{"id":"3575421087208890","authorId":"3575421087208890","name":"albert77","avatar":"https://static.tigerbbs.com/23ad8bf74e09800b779350089d72b84f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575421087208890","authorIdStr":"3575421087208890"},"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102117619","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102132499,"gmtCreate":1620183112611,"gmtModify":1634207153261,"author":{"id":"3581837767503148","authorId":"3581837767503148","name":"Huatchin","avatar":"https://static.tigerbbs.com/88efb7897819cfa26b956823fee031a1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581837767503148","authorIdStr":"3581837767503148"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/102132499","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4226928,"gmtCreate":1620183159072,"gmtModify":1635503123969,"authorId":3581493540228245,"author":{"id":3581493540228245,"idStr":"3581493540228245","authorId":3581493540228245,"name":"Heng83","avatar":"https://static.tigerbbs.com/d79bb76e32848f3d1fbfffd7c6bd2ebb","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102132499,"type":1,"supId":0,"prevId":0,"content":"Good","text":"Good","html":"Good"},{"id":4226941,"gmtCreate":1620183268182,"gmtModify":1635503122769,"authorId":3581493540228245,"author":{"id":3581493540228245,"idStr":"3581493540228245","authorId":3581493540228245,"name":"Heng83","avatar":"https://static.tigerbbs.com/d79bb76e32848f3d1fbfffd7c6bd2ebb","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102132499,"type":1,"supId":0,"prevId":0,"content":"Haut","text":"Haut","html":"Haut"},{"id":4227440,"gmtCreate":1620187043054,"gmtModify":1635503082422,"authorId":3569563989023705,"author":{"id":3569563989023705,"idStr":"3569563989023705","authorId":3569563989023705,"name":"rachhy","avatar":"https://static.tigerbbs.com/ac0d9804d3e4fa9220d45c8b779c2019","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102132499,"type":1,"supId":4226941,"prevId":0,"content":"<u>goood</u>","text":"<u>goood</u>","html":"<u>goood</u>"},{"id":4262203,"gmtCreate":1620460288161,"gmtModify":1635500409454,"authorId":3581493540228245,"author":{"id":3581493540228245,"idStr":"3581493540228245","authorId":3581493540228245,"name":"Heng83","avatar":"https://static.tigerbbs.com/d79bb76e32848f3d1fbfffd7c6bd2ebb","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102132499,"type":1,"supId":0,"prevId":0,"content":"Good ","text":"Good ","html":"Good "},{"id":4262216,"gmtCreate":1620460441109,"gmtModify":1635500408141,"authorId":3581493540228245,"author":{"id":3581493540228245,"idStr":"3581493540228245","authorId":3581493540228245,"name":"Heng83","avatar":"https://static.tigerbbs.com/d79bb76e32848f3d1fbfffd7c6bd2ebb","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102132499,"type":1,"supId":0,"prevId":0,"content":"Good ","text":"Good ","html":"Good "}],"langContent":"EN"},{"id":102133596,"gmtCreate":1620182655615,"gmtModify":1631883991232,"author":{"id":"3572916667219493","authorId":"3572916667219493","name":"Zarkness","avatar":"https://static.tigerbbs.com/4b8c61830c4883c4232aece921d89d14","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3572916667219493","authorIdStr":"3572916667219493"},"htmlText":"Which one u believe in? Or not ?","listText":"Which one u believe in? Or not ?","text":"Which one u believe in? Or not ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102133596","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102194643,"gmtCreate":1620182399382,"gmtModify":1634207159779,"author":{"id":"3581717184855315","authorId":"3581717184855315","name":"lynlim","avatar":"https://static.tigerbbs.com/e812bc79b9ab5a6da85c562179213b0c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3581717184855315","authorIdStr":"3581717184855315"},"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/102194643","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4226839,"gmtCreate":1620182638122,"gmtModify":1635503131679,"authorId":3572916667219493,"author":{"id":3572916667219493,"idStr":"3572916667219493","authorId":3572916667219493,"name":"Zarkness","avatar":"https://static.tigerbbs.com/4b8c61830c4883c4232aece921d89d14","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102194643,"type":1,"supId":0,"prevId":0,"content":"Hi lyn","text":"Hi lyn","html":"Hi lyn"},{"id":4226924,"gmtCreate":1620183110013,"gmtModify":1635503124298,"authorId":3572916667219493,"author":{"id":3572916667219493,"idStr":"3572916667219493","authorId":3572916667219493,"name":"Zarkness","avatar":"https://static.tigerbbs.com/4b8c61830c4883c4232aece921d89d14","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102194643,"type":1,"supId":4226839,"prevId":0,"content":"Hello","text":"Hello","html":"Hello"},{"id":4227051,"gmtCreate":1620183927437,"gmtModify":1635503114329,"authorId":3576831123463310,"author":{"id":3576831123463310,"idStr":"3576831123463310","authorId":3576831123463310,"name":"kctan","avatar":"https://static.tigerbbs.com/f1770830f8c002db55c8aadca0939107","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102194643,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":102190403,"gmtCreate":1620181756302,"gmtModify":1634207164776,"author":{"id":"3581926565619170","authorId":"3581926565619170","name":"7dee79ac","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581926565619170","authorIdStr":"3581926565619170"},"htmlText":"Pls like n comment","listText":"Pls like n comment","text":"Pls like n comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/102190403","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4226762,"gmtCreate":1620182139941,"gmtModify":1635503136918,"authorId":3575528814174823,"author":{"id":3575528814174823,"idStr":"3575528814174823","authorId":3575528814174823,"name":"Glenn101","avatar":"https://static.tigerbbs.com/9a6dce55b58bcea0be9143c1569dc7bd","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102190403,"type":1,"supId":0,"prevId":0,"content":"Like my reply!","text":"Like my reply!","html":"Like my reply!"},{"id":4226927,"gmtCreate":1620183135135,"gmtModify":1635503124078,"authorId":3572916667219493,"author":{"id":3572916667219493,"idStr":"3572916667219493","authorId":3572916667219493,"name":"Zarkness","avatar":"https://static.tigerbbs.com/4b8c61830c4883c4232aece921d89d14","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102190403,"type":1,"supId":4226762,"prevId":0,"content":"I like ur reply, ,/‘ can like my reply too?","text":"I like ur reply, ,/‘ can like my reply too?","html":"I like ur reply, ,/‘ can like my reply too?"}],"langContent":"CN"},{"id":102107368,"gmtCreate":1620181636154,"gmtModify":1634207166104,"author":{"id":"3576543142815799","authorId":"3576543142815799","name":"Julyvictor","avatar":"https://static.tigerbbs.com/46bde596fe80bee533460fc78fbc1d3b","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3576543142815799","authorIdStr":"3576543142815799"},"htmlText":"Comment done","listText":"Comment done","text":"Comment done","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/102107368","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4226991,"gmtCreate":1620183551817,"gmtModify":1635503118556,"authorId":3568626113017315,"author":{"id":3568626113017315,"idStr":"3568626113017315","authorId":3568626113017315,"name":"Sashiimi","avatar":"https://static.tigerbbs.com/cfb4827a74c92f32e435adf6eb295807","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102107368,"type":1,"supId":0,"prevId":0,"content":"DOnE","text":"DOnE","html":"DOnE"},{"id":4227441,"gmtCreate":1620187058858,"gmtModify":1635503082312,"authorId":3569563989023705,"author":{"id":3569563989023705,"idStr":"3569563989023705","authorId":3569563989023705,"name":"rachhy","avatar":"https://static.tigerbbs.com/ac0d9804d3e4fa9220d45c8b779c2019","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102107368,"type":1,"supId":4226991,"prevId":0,"content":"ya <u>alright</u>","text":"ya <u>alright</u>","html":"ya <u>alright</u>"}],"langContent":"EN"},{"id":102106833,"gmtCreate":1620181318722,"gmtModify":1620181318722,"author":{"id":"3576977788827352","authorId":"3576977788827352","name":"Skylarsong","avatar":"https://static.tigerbbs.com/9c12f47989722ef032fdbd3e4711955e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3576977788827352","authorIdStr":"3576977788827352"},"htmlText":"Wow a psychic!","listText":"Wow a psychic!","text":"Wow a psychic!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/102106833","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4226656,"gmtCreate":1620181383616,"gmtModify":1635503144652,"authorId":3575950181915531,"author":{"id":3575950181915531,"idStr":"3575950181915531","authorId":3575950181915531,"name":"njkk","avatar":"https://static.tigerbbs.com/6382201e8e84ccd3f8e89b9a28e74607","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102106833,"type":1,"supId":0,"prevId":0,"content":"Pls like and comment :)","text":"Pls like and comment :)","html":"Pls like and comment :)"},{"id":4226680,"gmtCreate":1620181507626,"gmtModify":1635503143241,"authorId":3576977788827352,"author":{"id":3576977788827352,"idStr":"3576977788827352","authorId":3576977788827352,"name":"Skylarsong","avatar":"https://static.tigerbbs.com/9c12f47989722ef032fdbd3e4711955e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102106833,"type":1,"supId":4226656,"prevId":0,"content":"I like pancakes","text":"I like pancakes","html":"I like pancakes"},{"id":4226885,"gmtCreate":1620182903429,"gmtModify":1635503127863,"authorId":3579413426750982,"author":{"id":3579413426750982,"idStr":"3579413426750982","authorId":3579413426750982,"name":"carmenng","avatar":"https://static.tigerbbs.com/b80cc1d0cc65b4923a58dcf0d330f19c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102106833,"type":1,"supId":0,"prevId":0,"content":"i like <u>waffles</u>","text":"i like <u>waffles</u>","html":"i like <u>waffles</u>"},{"id":4236829,"gmtCreate":1620265367191,"gmtModify":1635502352871,"authorId":3576977788827352,"author":{"id":3576977788827352,"idStr":"3576977788827352","authorId":3576977788827352,"name":"Skylarsong","avatar":"https://static.tigerbbs.com/9c12f47989722ef032fdbd3e4711955e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102106833,"type":1,"supId":4226885,"prevId":0,"content":"Life <u>ah</u>","text":"Life <u>ah</u>","html":"Life <u>ah</u>"}],"langContent":"EN"},{"id":102103342,"gmtCreate":1620181103286,"gmtModify":1634207169921,"author":{"id":"3582063338362819","authorId":"3582063338362819","name":"douknowdaway","avatar":"https://static.tigerbbs.com/fe319e138739a2e67529fe38221667c8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582063338362819","authorIdStr":"3582063338362819"},"htmlText":"Thanks for sharing, will look into these stocks&nbsp;more. Please like and comment! Much appreciated&nbsp;","listText":"Thanks for sharing, will look into these stocks&nbsp;more. Please like and comment! Much appreciated&nbsp;","text":"Thanks for sharing, will look into these stocks more. Please like and comment! Much appreciated","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/102103342","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4226632,"gmtCreate":1620181266398,"gmtModify":1635503146279,"authorId":3576135505707768,"author":{"id":3576135505707768,"idStr":"3576135505707768","authorId":3576135505707768,"name":"Jyen","avatar":"https://static.tigerbbs.com/26e6375f3ec665599c9d6faa652445e7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102103342,"type":1,"supId":0,"prevId":0,"content":"Reply please :)","text":"Reply please :)","html":"Reply please :)"},{"id":4226646,"gmtCreate":1620181338769,"gmtModify":1635503145415,"authorId":3575200533809324,"author":{"id":3575200533809324,"idStr":"3575200533809324","authorId":3575200533809324,"name":"Delvin","avatar":"https://static.tigerbbs.com/93738020b8156486e54265bfacf43f4b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102103342,"type":1,"supId":4226632,"prevId":0,"content":"ReplY back too","text":"ReplY back too","html":"ReplY back too"},{"id":4233042,"gmtCreate":1620231564131,"gmtModify":1635502666192,"authorId":3582063338362819,"author":{"id":3582063338362819,"idStr":"3582063338362819","authorId":3582063338362819,"name":"douknowdaway","avatar":"https://static.tigerbbs.com/fe319e138739a2e67529fe38221667c8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3575200533809324,"repliedAuthor":{"id":3575200533809324,"idStr":"3575200533809324","authorId":3575200533809324,"name":"Delvin","avatar":"https://static.tigerbbs.com/93738020b8156486e54265bfacf43f4b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":102103342,"type":1,"supId":4226632,"prevId":4226646,"content":"replied!","text":"replied!","html":"replied!"}],"langContent":"EN"},{"id":102109387,"gmtCreate":1620181065249,"gmtModify":1634207170612,"author":{"id":"3576135505707768","authorId":"3576135505707768","name":"Jyen","avatar":"https://static.tigerbbs.com/26e6375f3ec665599c9d6faa652445e7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3576135505707768","authorIdStr":"3576135505707768"},"htmlText":"Please like and comment!","listText":"Please like and comment!","text":"Please like and comment!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/102109387","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4226615,"gmtCreate":1620181133299,"gmtModify":1635503147902,"authorId":3582063338362819,"author":{"id":3582063338362819,"idStr":"3582063338362819","authorId":3582063338362819,"name":"douknowdaway","avatar":"https://static.tigerbbs.com/fe319e138739a2e67529fe38221667c8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102109387,"type":1,"supId":0,"prevId":0,"content":"done!","text":"done!","html":"done!"},{"id":4226666,"gmtCreate":1620181429092,"gmtModify":1635503144544,"authorId":3581761980405366,"author":{"id":3581761980405366,"idStr":"3581761980405366","authorId":3581761980405366,"name":"J288","avatar":"https://static.tigerbbs.com/f139ffb0e1f3cec014732c0986adcded","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102109387,"type":1,"supId":0,"prevId":0,"content":"sure","text":"sure","html":"sure"}],"langContent":"EN"},{"id":102100861,"gmtCreate":1620180980453,"gmtModify":1634207171075,"author":{"id":"3560204717545571","authorId":"3560204717545571","name":"Kok","avatar":"https://static.tigerbbs.com/efc25bb5380f85af49509ed68d9a3d8f","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3560204717545571","authorIdStr":"3560204717545571"},"htmlText":"Pls like n comment. Tks!!","listText":"Pls like n comment. Tks!!","text":"Pls like n comment. Tks!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/102100861","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4226609,"gmtCreate":1620181077096,"gmtModify":1635503148447,"authorId":3576135505707768,"author":{"id":3576135505707768,"idStr":"3576135505707768","authorId":3576135505707768,"name":"Jyen","avatar":"https://static.tigerbbs.com/26e6375f3ec665599c9d6faa652445e7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102100861,"type":1,"supId":0,"prevId":0,"content":"Done!","text":"Done!","html":"Done!"},{"id":4226634,"gmtCreate":1620181277909,"gmtModify":1635503146170,"authorId":3581761980405366,"author":{"id":3581761980405366,"idStr":"3581761980405366","authorId":3581761980405366,"name":"J288","avatar":"https://static.tigerbbs.com/f139ffb0e1f3cec014732c0986adcded","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102100861,"type":1,"supId":0,"prevId":0,"content":"Sure 😃","text":"Sure 😃","html":"Sure 😃"}],"langContent":"EN"},{"id":102100308,"gmtCreate":1620180965804,"gmtModify":1634207171197,"author":{"id":"3571345352614779","authorId":"3571345352614779","name":"小白添祥","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3571345352614779","authorIdStr":"3571345352614779"},"htmlText":"Kindly Like &amp; Comment Please. Thank You Very Much&nbsp;","listText":"Kindly Like &amp; Comment Please. Thank You Very Much&nbsp;","text":"Kindly Like & Comment Please. Thank You Very Much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/102100308","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4226596,"gmtCreate":1620180987408,"gmtModify":1635503149649,"authorId":3560204717545571,"author":{"id":3560204717545571,"idStr":"3560204717545571","authorId":3560204717545571,"name":"Kok","avatar":"https://static.tigerbbs.com/efc25bb5380f85af49509ed68d9a3d8f","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102100308,"type":1,"supId":0,"prevId":0,"content":"pls reply back. tks!!","text":"pls reply back. tks!!","html":"pls reply back. tks!!"},{"id":4226621,"gmtCreate":1620181188772,"gmtModify":1635503147360,"authorId":3576135505707768,"author":{"id":3576135505707768,"idStr":"3576135505707768","authorId":3576135505707768,"name":"Jyen","avatar":"https://static.tigerbbs.com/26e6375f3ec665599c9d6faa652445e7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102100308,"type":1,"supId":4226596,"prevId":0,"content":"Ok!","text":"Ok!","html":"Ok!"},{"id":4226622,"gmtCreate":1620181195166,"gmtModify":1635503147251,"authorId":3572672230120758,"author":{"id":3572672230120758,"idStr":"3572672230120758","authorId":3572672230120758,"name":"siewbee","avatar":"https://static.tigerbbs.com/aecff165cb101c9c535379b2947e2cbe","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102100308,"type":1,"supId":4226596,"prevId":0,"content":"Reply back pls","text":"Reply back pls","html":"Reply back pls"},{"id":4227232,"gmtCreate":1620185190812,"gmtModify":1635503100167,"authorId":3560204717545571,"author":{"id":3560204717545571,"idStr":"3560204717545571","authorId":3560204717545571,"name":"Kok","avatar":"https://static.tigerbbs.com/efc25bb5380f85af49509ed68d9a3d8f","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3572672230120758,"repliedAuthor":{"id":3572672230120758,"idStr":"3572672230120758","authorId":3572672230120758,"name":"siewbee","avatar":"https://static.tigerbbs.com/aecff165cb101c9c535379b2947e2cbe","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":102100308,"type":1,"supId":4226596,"prevId":4226622,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":4229538,"gmtCreate":1620206964034,"gmtModify":1635502921710,"authorId":3572826093389291,"author":{"id":3572826093389291,"idStr":"3572826093389291","authorId":3572826093389291,"name":"Tadalada","avatar":"https://static.tigerbbs.com/b72694826dfd7043f27335bde2e7e70b","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102100308,"type":1,"supId":0,"prevId":0,"content":"Pla reply back thanks ","text":"Pla reply back thanks ","html":"Pla reply back thanks "}],"langContent":"EN"},{"id":102377487,"gmtCreate":1620180933949,"gmtModify":1634207171318,"author":{"id":"3571183830721507","authorId":"3571183830721507","name":"Maxcrusader","avatar":"https://static.tigerbbs.com/a9dbd1695d1a45df589a4ba606e045e1","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3571183830721507","authorIdStr":"3571183830721507"},"htmlText":"Good read","listText":"Good read","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102377487","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102377841,"gmtCreate":1620180900683,"gmtModify":1634207171663,"author":{"id":"3562844889124170","authorId":"3562844889124170","name":"Prydeaux","avatar":"https://static.tigerbbs.com/4e1751a4d4fac98d06d321ef6407add9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3562844889124170","authorIdStr":"3562844889124170"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/102377841","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4226592,"gmtCreate":1620180966115,"gmtModify":1635503150083,"authorId":3571571652270606,"author":{"id":3571571652270606,"idStr":"3571571652270606","authorId":3571571652270606,"name":"Angelicious","avatar":"https://static.tigerbbs.com/8d6b3ad2e386906d2452bb855ce86640","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102377841,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":4226595,"gmtCreate":1620180984027,"gmtModify":1635503149758,"authorId":3562844889124170,"author":{"id":3562844889124170,"idStr":"3562844889124170","authorId":3562844889124170,"name":"Prydeaux","avatar":"https://static.tigerbbs.com/4e1751a4d4fac98d06d321ef6407add9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102377841,"type":1,"supId":4226592,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":102375381,"gmtCreate":1620180753843,"gmtModify":1634207173753,"author":{"id":"3571571652270606","authorId":"3571571652270606","name":"Angelicious","avatar":"https://static.tigerbbs.com/8d6b3ad2e386906d2452bb855ce86640","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3571571652270606","authorIdStr":"3571571652270606"},"htmlText":"Comment pls","listText":"Comment pls","text":"Comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/102375381","repostId":1183454115,"repostType":4,"repost":{"id":"1183454115","pubTimestamp":1620180427,"share":"https://www.laohu8.com/m/news/1183454115?lang=&edition=full","pubTime":"2021-05-05 10:07","market":"us","language":"en","title":"3 Stocks I Fully Expect to Double or More Within the Next 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1183454115","media":"The motley fool","summary":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare","content":"<p>DermTech</p><p><b>DermTech</b>(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.</p><p>The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.</p><p>DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.</p><p>It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.</p><p>But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.</p><p>Etsy</p><p>The Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years.&nbsp;<b>Etsy</b>(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.</p><p>There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.</p><p>In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.</p><p>Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.</p><p>Gores Holdings VI</p><p>I'm not usually a fan of special purpose acquisition company (SPAC) stocks. However,&nbsp;<b>Gores Holdings VI</b>(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.</p><p>Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.</p><p>The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.</p><p>Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks I Fully Expect to Double or More Within the Next 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks I Fully Expect to Double or More Within the Next 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it'...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc."},"source_url":"https://www.fool.com/investing/2021/05/04/3-stocks-i-fully-expect-to-double-or-more-within-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183454115","content_text":"DermTechDermTech(NASDAQ:DMTK)might scare off some investors because of its volatility. Thehealthcare stocksoared 145% year to date by late February only to give up much of those gains. In my view, it's best to ignore the short-term volatility and focus on DermTech's long-term prospects.The company markets two genomics tests for detecting melanoma called Pigmented Lesion Assay (PLA) and PLAPlus. With these tests, an adhesive patch is placed over a suspect area of skin. The patch is then removed and sent to DermTech's lab for genetic analysis.DermTech's tests are 17 times less likely to miss a melanoma diagnosis than the current method of obtaining a tissue biopsy and sending it to a lab for histological analysis. The cost of the PLA skin genomics test is also nearly 25% less expensive than the current approach.It's still in the really early innings for DermTech. Not every insurer covers the company's tests yet. Many dermatologists aren't familiar with the tests. DermTech is also still developing similar tests for other skin cancers.But I predict significantly increased payer coverage and dermatologist adoption as well as success for the company in launching new products over the next few years. With DermTech's market cap currently at around $1.2 billion, I think this stock has a great chance to double and perhaps deliver a much higher return.EtsyThe Motley Foolrecently revealed 20 of its highest-conviction stock and fund picksthat are in a great position to make investors money over the next five years. Etsy(NASDAQ:ETSY)ranked as the second smallest stock on the list with its market cap close to $25 billion. I also have a really high conviction about Etsy's potential.There's no doubt in my mind that online shopping will grow over the next several years. I think that Etsy will grow even faster than the overall e-commerce market. That was definitely the case in 2020, with Etsy's gross merchandise sales soaring 2.5 times faster than the U.S. Census Bureau's e-commerce industry benchmark.In my opinion, there's one main reason this trend is likely to continue: Etsy's uniqueness. The company's platform features many one-of-a-kind handcrafted products that you simply can't find anywhere else. This differentiation has helped make Etsy the fourth-largest e-commerce site in the U.S. based on monthly visits.Etsy could realistically double by focusing only on the $100 billion market for what it calls \"special\" products. However, the company is also targeting a broader e-commerce market that's much bigger. I look for Etsy to continue gaining market share and provide investors who buy and hold the stock huge gains over the next few years.Gores Holdings VII'm not usually a fan of special purpose acquisition company (SPAC) stocks. However, Gores Holdings VI(NASDAQ:GHVI)is an exception. I really like the prospects for the company that this SPAC plans to soon merge with -- Matterport.Matterport stands as the leader in creating 3D \"digital twins\" of buildings. It has created the world's biggest library of these 3D models with more than 10 billion square feet of space digitized. Matterport generates revenue primarily through a software-as-a-service model.The company estimates its total addressable market is close to $240 billion. The opportunities for its technology include facilities management, insurance pricing, interior design, and real estate marketing.Gores Holdings VI and Matterport expect the combined company will have a market cap of around $2.9 billion after their merger closes. That might seem like a steep valuation considering that Matterport made only $86 million in sales last year. However, the company thinks it could generate nearly six times that amount by 2025. If it even comes close to that goal, this SPAC stock should easily double or more within the next five years.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4226571,"gmtCreate":1620180830003,"gmtModify":1635503152035,"authorId":3547347450599561,"author":{"id":3547347450599561,"idStr":"3547347450599561","authorId":3547347450599561,"name":"Wanlin","avatar":"https://static.tigerbbs.com/65fdefa6dcf29500b8aa3b61f1f5d7e0","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102375381,"type":1,"supId":0,"prevId":0,"content":"Comment","text":"Comment","html":"Comment"},{"id":4226585,"gmtCreate":1620180937463,"gmtModify":1635503150734,"authorId":3560204717545571,"author":{"id":3560204717545571,"idStr":"3560204717545571","authorId":3560204717545571,"name":"Kok","avatar":"https://static.tigerbbs.com/efc25bb5380f85af49509ed68d9a3d8f","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102375381,"type":1,"supId":4226571,"prevId":0,"content":"pls reply back. tks!!","text":"pls reply back. tks!!","html":"pls reply back. tks!!"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":48,"commentSize":24,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}